Duoneb and Glucagon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duoneb (albuterol sulfate; ipratropium bromide) and Glucagon (glucagon hydrochloride). Common drug interactions include hypotension among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Duoneb and Glucagon. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.



On Jul, 15, 2026

76 people who take Duoneb and Glucagon together, and have interactions are studied.

Duoneb and Glucagon drug interactions.

What are the common drug interactions of Duoneb and Glucagon, by gender? *:

female:

  1. Hypotension (abnormally low blood pressure)
  2. Leukocytosis (increased white blood cells)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Asthenia (weakness)
  6. Blood glucose increased
  7. Decreased appetite
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. General physical health deterioration (weak health status)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

male:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Chest pain
  4. Constipation
  5. Cytomegalovirus infection
  6. Death
  7. Fall
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Duoneb and Glucagon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  3. Oesophageal obstruction (blockage of oesophagus)
  4. Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)

40-49:

  1. Subcutaneous abscess
  2. Abscess (pus)
  3. Abscess limb (limb infection)
  4. Cellulitis (infection under the skin)
  5. Escherichia sepsis (bacterial infection by escherichia coli)
  6. Groin abscess (pus in groin)
  7. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  8. Perineal abscess
  9. Perirectal abscess
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Cardiogenic shock (inadequate circulation of blood)
  3. Chest pain
  4. Cough
  5. Dyspnoea (difficult or laboured respiration)
  6. Fatigue (feeling of tiredness)
  7. Fungaemia (fungi circulate in the blood)
  8. Gastritis (inflammation of stomach)
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

60+:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Weight decreased
  4. Acute respiratory failure
  5. Asthenia (weakness)
  6. Fall
  7. Fatigue (feeling of tiredness)
  8. General physical health deterioration (weak health status)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Pleural effusion (water on the lungs)

What are the existing conditions these people have? *

  1. Pain: 19 people, 25.00%
  2. Stress And Anxiety: 9 people, 11.84%
  3. Nausea (feeling of having an urge to vomit): 9 people, 11.84%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 10.53%
  5. Diabetes: 7 people, 9.21%
  6. Wheezing (a high-pitched whistling sound made while you breath): 6 people, 7.89%
  7. Hypoglycemia (low blood sugar): 6 people, 7.89%
  8. Constipation: 6 people, 7.89%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 7.89%
  10. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and Glucagon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Duoneb and Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duoneb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucagon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide and glucagon hydrochloride (the active ingredients of Duoneb and Glucagon, respectively), and Duoneb and Glucagon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: